AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
PR Newswire —
AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the...